SEC Form 4 · accession 0001209191-18-033918
VivoSim Labs, INC. · VIVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Taylor Crouch
Officer — CEO & President · Director
Period of report
May 24, 2018
Accepted (ET)
May 29, 2018 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | May 24, 2018 | A | 148,760 | $0.00 | A | 148,760 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $1.84 | May 24, 2018 | A | 600,000 | A | — | May 24, 2028 | Common Stock | 600,000 | 600,000 | D |
Explanation of responses
- F1Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors.
- F2The shares represent a grant of Restricted Stock Units ("RSUs"). The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price. The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2018.
- F3This number does not include 2,688,212 shares of common stock underlying outstanding options held by Mr. Crouch; post-transaction Mr. Crouch continues to beneficially own or have a right to acquire 2,836,972 shares of common stock.
- F4The option shares vest and become exercisable over 16 equal quarterly installments measured from May 15, 2018.